Company: CDT
Filing Date: 2025-08-14
Form Type: 10-Q/A
Source: 0001641172-25-024123
Chunk: 0

Company: CDT Equity Inc.
Filing Date: 2025-08-14
Form: 10-Q/A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Amendment No. 1)

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-41245

CDT EQUITY INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware                                       |     |     87-3272543 |
| (State                                         
 or other jurisdiction of                       
 incorporation                                  
 or organization)                               |     |        -I.R.S. 
       Employer 
 Identification 
            No. |
| 4581                                           
 Tamiami Trail North, Suite 200 Naples, Florida |     |          34103 |
| (Address                                       
 of Principal Executive Offices)                |     |           -Zip 
           Code |

| (646)                                                                      
 491-9132                                                                   |
| (Registrant’s                                                              
 telephone number, including area code)                                     |
| Conduit Pharmaceuticals, Inc.                                              |
| (Former                                                                    
 name, former address and former fiscal year, if changed since last report) |

Securities registered pursuant to Section 12(b) of the Act:

| Title                                                                                                    
 of each class                                                                                            |     | Trading   
 Symbol(s) |     | Name                                 
 of each exchange on which registered |
| Common                                                                                                   
 Stock, par value $0.0001 per share                                                                       |     | CDT       |     | The                                  
 Nasdaq Stock Market LLC              |
| Redeemable                                                                                               
 Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $1,150.00 |     | CDTTW     |     | The                                  
 Nasdaq Stock Market LLC              |

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject